1Ritva Heljasvaara, Pia Nyberg,Jani Luostarinen, et al. Generation of biologically active endostatin fragments from human collagen ⅩⅧ by distinct matrix metalloproteases. Experimental Cell Research, 2005 ,307 (2) :292 - 304.
2David Hui-Kang Ma, Jeng-Yuan Yao, Ming-Tse Kuo,Let al. Generation of Endostatin by Matrix Metalloproteinase and Cathepsin from Human Limbocorneal Epithelial Cells Cultivated on Amniotic Membrane. Investigative Ophthalmology and Visual Science, 2007,48 : 644 - 651.
3Ilhan Celik, Oguzkan Surucu, Carsten Dietz, et al. Therapeutic Efficacy of Endostatin Exhibits a Biphasic Dose-Response Curve. Cell and Tumor Biology ,2005,65 ( 23 ) : 11044 - 50.
4Yuan S, Fu Y, Wang X, et al. Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. FASEB, 2008,22(8) :2809 -20.
5Kang HY, Shim D, Kang SS, et al. Protein Kinase B Inhibits Endostatin-induced Apoptosis in HUVECs. J Biochem Mol Biol,2006, 39(1) :97 -104.
6Sundaram Ramakrishnan,Tri Minh Bui Nguyen, Indira V. Subramanian, et al. Autophagy and Angiogenesis Inhibition. Autophagy, 2007,3(5) :512 -5.
7Reis RC, Schuppan D, Barreto AC, et al. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans. Biochem Biophys Res Commun ,2005,333 ( 3 ) :976 - 83.
8Hubing Shi, Yujie Huang, Hao Zhou, et al. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood,2007,110(8) :2899 -906.
9Christie E. Delaney, Brodie T. Weagant, Christina L. Addison. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix. Exp Cell Res ,2006,312 ( 13 ) :2476 - 89.
10David M Neskey, Anthony Ambesi, Kevin M Pumiglia, et al. Endostatin and anastellin inhibit distinct aspects of the angiogenic process. J Exp Clin Cancer Res,2008,27 ( 1 ) :61.
6Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia [ J ]. Nature, 1989, 339(6129) : 58 -61.
7Brideau G, Makinen M J, Elamas H, et al. Endostatin overex- pression inhibits lymphangiogenesis and lymph node metastasis in mice[J]. Cancer Res, 2007, 67(24): 11528-11535.
8Tang PA, Bentzen SM, Chen EX, et al. Surrogate end points for median overall survival in metastatic colorectal cancer: literature- based analysis from 39 randomized controlled trials of first-line chemotherapy [ J ]. J Clin Oncol, 2007, 25 (29) : 4562 - 4568.
9Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab pXus irinotecan, fluorouracil, and leucovorin for metastatic color- ectal cancer[ J ]. N Engl J Med, 2004, 350 (23) : 2335 - 2342.
10Saltz L, Clarke S, Diaz-Rubio E, et al. Bevacizumab in combi- nation with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer : a randomized phase Ⅲ study[ J]. J Clin Oncol, 2008, 26( 12): 2013 -2019.
